PHARMA | PHARMANIAGA BHD

99
0.675 (0.75%)

T-O: 0.675 (08:44:00)
Last updated: 17:00

Fundamental
Technical
Total Score

PHARMA | PHARMANIAGA BHD


iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Trailing Dividend

Financial Ratios

EPS13.49 sen
Trailing PE (Sector Median: 17.7)5.0
PEG0.05
Altman Z2.3
Beaver0.005
Current Ratio1.08
Debt-Equity (DE) Ratio4.91
FCF Yield-1.45 %
Revenue QoQ21.26 %
Revenue YoY84.67 %
Profit QoQ19.87 %
Profit YoY526.19 %
Profit Margin (Sector Median: 5.2)3.55 %
ROE (ROIC: 24.77)42.68 %
Dividend Per Share (DPS)9.3 sen
Dividend Yield (DY)13.78 %

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 3 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA)0.32
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M]30.99
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M)330.12
Expected Revenue (M)31439.92
Expected Growth (%)38.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


No transaction in the last 2 months.

Summary


Market Cap: 884 M.

Number of Shares: 1309 M.

Adjusted Float: 33.0%.

Stock highly correlated with

DPHARMA (75%)

SMCAP (70%)

XOXTECH (70%)

DIGISTA (68%)

Pharmaniaga Berhad, through its subsidiaries, operates as an integrated healthcare company. It is engaged in the logistics and distribution; sale and marketing; and research, development, and manufacture of generic pharmaceuticals, as well as the supply of medical products and services; hospital equipping; and provision of information technology solutions. It is also involved in the sale and distribution of portable medical devices; contract manufacturing; and distribution and trade of pharmaceuticals products, food supplements, and diagnostics products. Pharmaniaga sells its products and services to the public and private sectors primarily in Malaysia and Indonesia. The company was founded in 1994 and is based in Shah Alam, Malaysia. Pharmaniaga Bhd operates as a member of UEM Group.

Sectors: Trading & Services, Healthcare, Pharmaceuticals, Post MCO, Vaccine

Code: 7081

Website: http://www.pharmaniaga.com/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

Top Shareholdings

Updated on 3-May-2021

ShareholderValue (M)
Boustead Holdings Berhad98.62
Lembaga Tabung Angkatan Tentera19.73
Great Eastern Life Assurance (Malaysia) Berhad3.9
Dasar Technologies Sdn Bhd1.32
Syarikat Takaful Malaysia Keluarga Berhad1.32
Che Lodin Bin Wok Kamaruddin1.06
Kumpulan Wang Persaraan (Diperbadankan)0.81
Citigroup Nominees (Asing) Sdn Bhd UBS AG0.65
Chinchoo Investment Sdn. Berhad0.62
Employees Provident Fund Board0.55
Yong Siew Yoon0.55
Gibraltar BSN Aggressive Fund0.51
Gan Teng Siew Realty Sdn. Berhad0.44
Vathivaloo A/L A.S Ramaiah0.44
Yayasan LTAT0.41
UOB Kay Hian Pte Ltd0.37
Tan Heng Loon0.35
Key Development Sdn. Berhad0.35
Venudran A/L Raman0.32
Fong Ming Sang0.32
Gemas Bahru Estates Sdn. Bhd.0.3
Bidor Tahan Estates Sdn.Bhd.0.26
Mikdavid Sdn Bhd0.25
Yeo Ann Seck0.25
PMB Shariah Dividend Fund0.23

This calculator use Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator use Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.